MJT-30882-99185
2 vaccinations
1 coded response
5 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 973 / OR
- Registered
- 2021-10-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-03
Dose 1 — Pfizer-BioNTech
-
2021-10-08
Dose 2 — Pfizer-BioNTech
-
2021-10-09
Registered in v-safe
-
2021-10-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-10-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-10-14
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Fair · Joint pains, Muscle or body achesFree text: My family has COVIDMedDRA releases: 2024-11 · check-in free text available
- 2021-10-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-03 | Pfizer-BioNTech | No |
| 2 | 2021-10-08 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): My family has COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release